#+STARTUP: beamer
#+TITLE: On the challenges of predicting treatment response
#+TITLE: in schizophrenia
* Preamble                                                      :ignore:
** Comments                                                     :ignore:
# ----------------------------------------------------------------------
# - Turn on synonyms by starting synosaurus-mode
# - Look up words using C-c sr
# - Turn on dictionary by starting flyspell-mode
# - Count words by section using org-wc-display
# ----------------------------------------------------------------------
** org specific settings                                        :ignore:
# ----------------------------------------------------------------------
#+OPTIONS: email:nil toc:nil num:nil title:t author:nil date:nil tex:t 
#+STARTUP: align fold logdone
#+SEQ_TODO: TODO(t) INPROGRESS(i) WAITING(w) | DONE(d) CANCELED(c)
#+TAGS: figure(f) check(c) noexport(n) ignore(i)
#+LANGUAGE: en
#+EXCLUDE_TAGS: noexport TODO
# ----------------------------------------------------------------------
** Latex header                                                 :ignore:
# ----------------------------------------------------------------------
#+LATEX_CLASS:  mybeamerfeinstein
#+LATEX_HEADER: \usepackage{graphicx}
#+LATEX_HEADER: \usepackage{setspace}
#+LATEX_HEADER: \usepackage{amsmath}
#+LATEX_HEADER: \usepackage{fontspec}
#+LATEX_HEADER: \usepackage{textpos}
#+LATEX_HEADER: \usepackage{bibentry}
#+LATEX_HEADER: \graphicspath{{../../../output/figures/}{../../../ext/logos/}}
# LATEX_HEADER: \graphicspath{{../../../ext/logos/}}
# ----------------------------------------------------------------------
** Latex macros                                               :ignore:
# ----------------------------------------------------------------------
#+LATEX_HEADER: \newcommand{\auth}{Philipp Homan, MD, PhD}
#+LATEX_HEADER: \newcommand{\authemail}{phoman1@northwell.edu}
#+LATEX_HEADER: \newcommand{\authtwitter}{@philipphoman}
#+LATEX_HEADER: \newcommand{\authgithub}{github.com/philipphoman}
# ----------------------------------------------------------------------
** Beamer-specific header                                       :ignore:
# ----------------------------------------------------------------------
#+LaTeX_CLASS_OPTIONS: [aspectratio=169, bigger]
# ----------------------------------------------------------------------
** Authors and affiliations                                     :ignore:
# ----------------------------------------------------------------------
#+LATEX_HEADER: \author{Philipp Homan\inst{1,2,3}, MD, PhD}
#+LATEX_HEADER: \institute[shortinst]{\inst{1} Donald and  
#+LATEX_HEADER: Barbara Zucker School of Medicine 
#+LATEX_HEADER: at Northwell/Hofstra, NY, USA
#+LATEX_HEADER: \and \inst{2} Feinstein Institute for Medical 
#+LATEX_HEADER: Research, Manhasset, NY, USA \and
#+LATEX_HEADER: \inst{3} Zucker Hillside Hospital, NY, USA\\ 
#+LATEX_HEADER: \footnotesize\vspace{5mm}
#+LATEX_HEADER: \url{phoman1@northwell.edu}\\
#+LATEX_HEADER: \url{http://github.com/philipphoman}}
# ----------------------------------------------------------------------

** Buffer-wide source code blocks                             :ignore:
# ----------------------------------------------------------------------
# Set elisp variables need for nice formatting We want no new lines in
# inline results and a paragraph size of 80 characters Important: this
# has to be evaluated witch C-c C-c in order to work in the current
# buffer
#+BEGIN_SRC emacs-lisp :exports none :results silent

; set timestamp format
;(setq org-export-date-timestamp-format "%ft%t%z")
(require 'org-wc)
(flyspell-mode t)
(synosaurus-mode t)
(auto-complete-mode t)
(linum-mode t)
(whitespace-mode t)
(setq org-babel-inline-result-wrap "%s")
(setq org-export-with-broken-links "mark")
(setq fill-column 72)
(setq whitespace-line-column 72)
;(setq org-latex-caption-above '(table image))
(setq org-latex-caption-above nil)
(org-toggle-link-display)
; don't remove logfiles at export
(setq org-latex-remove-logfiles nil)

; keybindings
; (global-set-key (kbd "<f7> c") "#+CAPTION: ")
(defun setfillcolumn72 ()
	(interactive)
	(setq fill-column 72)
)

(defun setfillcolumn42 ()
	(interactive)
	(setq fill-column 42)
)
(define-key org-mode-map (kbd "C-c #") "#+CAPTION: ")
(define-key org-mode-map (kbd "C-c f c 4 2") 'setfillcolumn42)
(define-key org-mode-map (kbd "C-c f c 7 2") 'setfillcolumn72)

(setq org-odt-category-map-alist
	 '(("__figure__" "*figure*" "value" "figure" org-odt--enumerable-image-p)))

; let ess not ask for starting directory
(setq ess-ask-for-ess-directory nil)

;(setq org-latex-pdf-process '("latexmk -pdflatex='xelatex
;-output-directory=../output/tex/ -interaction nonstopmode' -pdf
;-bibtex -f %f"))

;(setq org-latex-pdf-process '("latexmk -pdf 
;	-pdflatex='xelatex -shell-escape -interaction nonstopmode' -bibtex -f %f "))
(setq org-latex-pdf-process '("latexmk -pdflatex='xelatex -interaction nonstopmode' -shell-escape -pdf -bibtex -f %f"))

(setq org-latex-logfiles-extensions 
	 (quote("bcf" "blg" "fdb_latexmk" "fls" 
	 "figlist" "idx" "log" "nav" "out" "ptc" 
	 "run.xml" "snm" "toc" "vrb" "xdv")))

(add-to-list 'org-structure-template-alist
 '("ca" "#+CAPTION: "))

(add-to-list 'org-structure-template-alist
 '("he" "#+LATEX_HEADER: "))

(add-to-list 'org-structure-template-alist
 '("dc" "src_R[:session]{}"))

(add-to-list 'org-structure-template-alist
 '("sr" "#+HEADER: :exports none
,#+BEGIN_SRC R :colnames yes :results silent :session\n")) 

(add-to-list 'org-structure-template-alist
 '("er" "#+END_SRC"))
 
(setq attrlatex "#+ATTR_LATEX: :width 1.0")

(define-key org-mode-map (kbd "C-c #") attrlatex)


(add-to-list 'org-structure-template-alist
	'("cl" "\n** Left\n:PROPERTIES: ?\n:BEAMER_col: 0.5 \n:END:"))

(add-to-list 'org-structure-template-alist
	'("cr" "\n** Right\n:PROPERTIES: ?\n:BEAMER_col: 0.5 \n:END:"))

(add-to-list 'org-structure-template-alist
	'("im" "#+ATTR_LATEX: :width 1.0\\textwidth \n[[file:"))

(add-to-list 'org-structure-template-alist
	'("qt" "\\center \n\\tiny\n"))




#+END_SRC
# ----------------------------------------------------------------------
# End preamble
# ----------------------------------------------------------------------
# Start with doublespacing 
\clearpage

* References                                                    :ignore:
\bibliographystyle{npp}
\nobibliography{master} 

* Imprecision medicine 
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
if (grepl("Zurich2018", getwd())) { 
  setwd("../../../src/")
}

#-----------------------------------------------------------------------
# load fe data to obtain slopes
#-----------------------------------------------------------------------
source("fe_load.R")
#-----------------------------------------------------------------------
#+END_SRC
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: 
:END:
#+ATTR_LATEX: :width 0.55\textwidth
[[file:fe_zh2018_schork2015.png]]
\center
\tiny
Schork 2015, Nature 

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [b]
:END:

``Every day, millions of people are taking medications that will not
help them.''
# The top ten highest-grossing drugs in the United States help
# between 1 in 25 and 1 in 4 of the people who take them.''

* Why prediction?
- Assumption: great variability in treatment response
- There exist /responders/ und /non-responders/
- Ultimate goal: to know before treatment who is going to respond
- ``precision medicine'', ``individualized medicine'', ``personalized
  medicine''

* Outline
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Complexity of the human brain

#+ATTR_LATEX: :width 0.8\textwidth
[[file:fe_iw2018_bassett2015a.pdf]]
# [[file:fe_grid9333.pdf]]
\center
\tiny
Image credit: Dani Bassett, PhD, U Penn

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Complexity of treatment response

#+ATTR_LATEX: :width 0.8\textwidth 
[[file:fe_iw2018_nature2014.pdf]]

* Responders and non-responders  
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:END:

#+ATTR_LATEX: :width 1.0\textwidth 
[[file:fe_iw2018_palaniyappan2015.pdf]]
\center
\tiny
Palaniyappan et al. 2015

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:END:

#+ATTR_LATEX: :width 1.0\textwidth 
[[file:fe_zh2018_homan2012a.pdf]]
\center
\tiny
Homan et al. 2012

* Responders and non-responders
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:

#+ATTR_LATEX: :width 1.0\textwidth 
[[file:fe_iw2018_senn2003.pdf]]

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:

#+ATTR_LATEX: :width 0.3\textwidth 
[[file:fe_iw2018_senn2003a.pdf]]

* A clinical vignette
- Mister K., 24 year old car mechanic from Nassau County, NY
- Psychotic symptoms with delusions and suspiciousness
- Duration of untreated psychosis: about 1 year 
- 07.01.2014: Admission to psychiatric hospital

* A clinical vignette
Question: which medication is likely to work?

* Outcome
** Left                                                         :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: 
:END:
#+ATTR_LATEX: :width 1.0\textwidth
[[file:fe_iw2018_festudy_grid9333.pdf]]

** Right                                                        :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- Trajectory of a 12 week treatment 
- Medication: risperidone 1-6 mg 
	
* Another vignette
- Mister L., *1991, high school graduate from Queens, NYC
- Paranoid ideas  
- Untreated psychosis for about 4 years 
- 23.08.2011: Admission
	
* Another vignette
** Left                                                         :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
#+ATTR_LATEX: :width 1.0\textwidth
[[file:fe_iw2018_festudy_grid9618.pdf]]

** Right                                                        :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- Trajectory of a 12 week treatment 
- Medication: Aripiprazole 5-15 mg 
	
* Conclusions
What do we learn from the two clinical vignettes?

* Conclusions
- Mister K. responded to the treatment, Mister L. didn't?
- Risperidone was helpful, aripiprazole wasn't?

* Risperidone vs. Aripiprazole
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
#-----------------------------------------------------------------------
# demonstrate similarity of risperidone and aripiprazole
#-----------------------------------------------------------------------
exweeks <- c(0, 1, 2, 3, 4, 6, 8, 10, 12)
fef1 <- fef %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  mutate(study=med)

feo1 <- feo %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  rename(study=med)
feo1$med = "Risperidone"

df1 <- rbind(fef1, feo1) %>% filter(visit %in% exweeks)

dfm <- df1 %>% group_by(study, visit) %>%
dplyr::summarize(mean=mean(y, na.rm=TRUE),
								 sd=sd(y, na.rm=TRUE),
								 n=sum(!is.na(y)),
								 se=sd/sqrt(n),
								 ci=1.96 * se)

pd <- position_dodge(0.5)
g <- ggplot(dfm, aes(x=visit, y=mean, color=study)) +
geom_line(size=1.0, position=pd) +
geom_point(size=3.5, position=pd) +
geom_errorbar(size=1.0, 
							aes(ymin=mean-ci, ymax=mean+ci), width=.0,
						 position=pd) +
theme_classic(base_size=30) +
theme(
	axis.title=element_text(face="bold"),
	axis.text=element_text(),
	legend.text=element_text(),
	legend.title=element_blank(),
  legend.key.height=unit(1.5, "line"),
	legend.position="right"
) +
scale_color_manual(values=c("darkblue", "darkcyan")) +
xlab("Week") +
ylab("Thinking Disturbance BPRS")


#p <- (plot_average(rbind(fef1, feo1) %>% filter(visit %in% exweeks)))
ggsave("../output/figures/fe_zh2018_homan2018b.pdf", plot=g, width=12.5,
       height=6.99)
#-----------------------------------------------------------------------
 
#+END_SRC
** Slide                                                        :ignore:
*** Left                                                         :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth
file:fe_iw2018_robinson2015.png

*** Right                                                        :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth
file:fe_zh2018_homan2018b.pdf

* Risperidone vs. Aripiprazole
- On average no sig. difference between risperidone und
  aripiprazole
- Not so in the single case!

* The single case is our patient
- As doctors we treat single patients, not averages
- There is no such thing as an ``average patient'' 

* A bunch of single cases
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
#-----------------------------------------------------------------------
# demonstrate similarity of risperidone and aripiprazole
#-----------------------------------------------------------------------
exweeks <- c(0, 1, 2, 3, 4, 6, 8, 10, 12)
fef1 <- fef %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  mutate(study=med)

feo1 <- feo %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  rename(study=med)
feo1$med = "Risperidone"

df1 <- rbind(fef1, feo1) %>% filter(visit %in% exweeks)

g2 <- ggplot(df1, aes(x=as.factor(visit), y=y, group=grid)) +
geom_line(aes(col=study)) +
geom_point(aes(col=study)) +
theme_classic(base_size=30) +
theme(
	axis.title=element_text(face="bold"),
	axis.text=element_text(),
	legend.text=element_text(),
	legend.title=element_blank(),
  legend.key.height=unit(1.5, "line"),
	legend.position="right"
) +
scale_color_manual(values=c("darkblue", "darkcyan")) +
xlab("Week") +
ylab("Thinking Disturbance BPRS")


#p <- (plot_average(rbind(fef1, feo1) %>% filter(visit %in% exweeks)))
ggsave("../output/figures/fe_zh2018_robinson2015b.pdf", plot=g2, width=12.5,
       height=6.99)
#-----------------------------------------------------------------------

#+END_SRC

** Slide                                                        :ignore:
#+ATTR_LATEX: :width 0.8\textwidth
file:fe_zh2018_robinson2015b.pdf

* Interim summary
- RCTs tell us about the efficacy on average 
- In clinical practice we treat individual patients
- Our impression: patients respond differently 
  to the treatment (Mister L. and Mister K.)
	
* Is this actually true?
- We don't know!
- Not only do we not know, we cannot know
- Why not?

* Components of the treatment effect  
1. Drug effect
2. Placebo effect
3. Random fluctuations of symptoms (``regression to the mean'')

* Regression to the mean
** Left
:PROPERTIES:
:BEAMER_col: 0.5
:END:
#+ATTR_LATEX: :width 1.0\textwidth
file:fe_iw2018_tverskykahneman.png
\tiny
Amos Tversky (1937 - 1996) and Daniel Kahneman (*1934)

** Right
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- Regression to the mean is ubiquitous
- Definition: outliers will be closer to the mean when measured again
- Easy to be fooled by regression to the mean
- Example: a highly symptomatic patient will most likely be less
  symptomatic when tested again
	
* Symptomatic patients respond better
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
if (grepl("Zurich2018", getwd())) { 
  setwd("../../../src/")
}

#-----------------------------------------------------------------------
# load fe data to obtain slopes
#-----------------------------------------------------------------------
source("fe_load.R")
#-----------------------------------------------------------------------

#-----------------------------------------------------------------------
# load concatenate slopes, calculate correlations of baseline with slope
#-----------------------------------------------------------------------
slopes <- rbind(slopes1 %>%
                mutate(study=paste("CIDAR trial", " (N=",
                                   nrow(slopes1), ")", sep="")),
                slopes2 %>%
                mutate(study=paste("Omega-3 trial", " (N=",
                                   nrow(slopes2), ")", sep="")))
rstats <- by(slopes, slopes$study, lm, 
             formula=formula("scale(slope) ~ scale(bprs_tdbl)"))
rdf <- data.frame(r=c(coef(summary(rstats[[1]]))[2],
                      coef(summary(rstats[[2]]))[2]),
                  pval=c(coef(summary(rstats[[1]]))[8],
                         coef(summary(rstats[[1]]))[8]))
rdf$sign <- starsfromp(rdf$pval)											
#-----------------------------------------------------------------------

#-----------------------------------------------------------------------
# graph of correlations of baseline and slope by trial (cidar, omega)
#-----------------------------------------------------------------------
p <- ggplot(slopes, aes(x=bprs_tdbl, y=slope)) +
  geom_point(size=4) +
  geom_smooth(method="lm") +
  facet_wrap(~study) +
  theme_gray(base_size=30) +
  xlab("Baseline pos. symptoms") +
  ylab("BLUP") +
  annotate("text", x=Inf, y=Inf,
           label=paste("r=", round(rdf$r, 2),
                       rdf$sign, sep=""),
           size=6, hjust=1, vjust=1)
ggsave(p, filename="../output/figures/fe_zh2018_homan2018.pdf",
       width=11.6, height=6.39)
#-----------------------------------------------------------------------

#+END_SRC

** Slide                                                        :ignore:
#+ATTR_LATEX: :width 0.8\textwidth
file:fe_zh2018_homan2018.pdf
\center 
\tiny
Homan et al., under review

* Symptomatic patients respond better
- Typical case of regression to the mean 
- Purely statistical phenomenon
- No causal explanation 

* Placebo effect
** Left                                                         :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth
file:fe_iw2018_hrobjartsson2001a.png
\tiny
Hrobjartsson und Gotzsche, 2001, N Engl J Med

** Right                                                        :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth
file:fe_iw2018_hrobjartsson2001.png

* Components of the treatment effect
1. Drug effect
2. Placebo effect
3. Regression to the mean
Regression to the mean most likely stronger than placebo
effect!

* What does this mean for clinical practice?
- When we treat a patient with a particular drug, we tend to only see
  the drug effect
- But we do not know how strong each was: drug, placebo, regresssion to
  the mean
- Easy to draw the wrong conclusions

* How big is the variation in drug response? 
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 0.5\textwidth 
[[file:fe_iw2018_cortes2018.pdf]]
\center 
\tiny
Cortes et al. 2018
# [[file:fe_iw2018_fisher1938.pdf]]
# \center 
# \tiny
# Sir Ronald Fisher, 1890 - 1962

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:

#+ATTR_LATEX: :width 1.0\textwidth
file:fe_zh2018_winkelbeiner2018.png
\center 
\tiny
Winkelbeiner, Leucht, Kane & Homan, in prep.

* How big is the variation in drug response? 
#+ATTR_LATEX: :width 0.6\textwidth
file:fe_zh2018_winkelbeiner2018e.png
\center 
\tiny
Winkelbeiner, Leucht, Kane & Homan, in prep.

* Interim results
- The assumption that patients vary strongly in their drug response is
  just that: an assumption
- Little evidence from clinical trials
- In the noisy clinical environment it is difficult if not impossible to
  distinguish effects of drug, placebo, and regression to the mean

* So what can we do instead?  
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
#-----------------------------------------------------------------------
# demonstrate similarity of risperidone and aripiprazole
#-----------------------------------------------------------------------
exweeks <- c(0, 1, 2, 3, 4, 6, 8, 10, 12)
fef1 <- fef %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  mutate(study=med)

feo1 <- feo %>% dplyr::select(grid, bprs_td, med,
                              visit, included16w)  %>%
    rename(y=bprs_td) %>%
  rename(study=med)
feo1$med = "Risperidone"

df1 <- rbind(fef1, feo1) %>% filter(visit %in% exweeks)

g2 <- ggplot(df1, aes(x=as.factor(visit), y=y, group=grid)) +
geom_line(aes(col=study)) +
geom_point(aes(col=study)) +
theme_classic(base_size=30) +
theme(
	axis.title=element_text(face="bold"),
	axis.text=element_text(),
	legend.text=element_text(),
	legend.title=element_blank(),
  legend.key.height=unit(1.5, "line"),
	legend.position="right"
) +
scale_color_manual(values=c("darkblue", "darkcyan")) +
xlab("Week") +
ylab("Thinking Disturbance BPRS")


#p <- (plot_average(rbind(fef1, feo1) %>% filter(visit %in% exweeks)))
ggsave("../output/figures/fe_zh2018_robinson2015b.pdf", plot=g2, width=12.5,
       height=6.99)
#-----------------------------------------------------------------------

#+END_SRC

** Slide                                                        :ignore:
#+ATTR_LATEX: :width 0.8\textwidth
file:fe_zh2018_robinson2015b.pdf

* Individual trajectories and partial pooling
#+ATTR_LATEX: :width 0.9\textwidth 
[[file:fe_iw2018_homan2018a.pdf]]
\center 
\tiny
Homan et al., under review

* Outline
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Complexity of the human brain

#+ATTR_LATEX: :width 0.8\textwidth
[[file:fe_iw2018_bassett2015a.pdf]]
# [[file:fe_grid9333.pdf]]
\center
\tiny
Image credit: Dani Bassett, PhD, U Penn

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Complexity of treatment response

#+ATTR_LATEX: :width 0.8\textwidth 
[[file:fe_iw2018_nature2014.pdf]]

* Predicting the individual trajectories 
#+ATTR_LATEX: :width 0.7\textwidth 
[[file:fe_iw2018_homan2018b.pdf]]
\center 
\tiny
Homan et al., under review

* Nodal degree and clinical response
#+ATTR_LATEX: :width 0.5\textwidth 
[[file:fe_iw2018_homan2018c.png]]
\center 
\tiny
Homan et al., under review

* Relevance of hubs for schizophrenia
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 0.6\textwidth 
[[file:fe_iw2018_crossley2014.png]]

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth 
[[file:fe_iw2018_crossley2014a.pdf]]
\center
\tiny
Crossley et al. 2014

* What is the biological meaning?
- Structural similarity networks capture functionally relevant
  developmental maturation
- Brain regions that covary in their degree are likely to be
  developmentally related
- Structural connectomics may provide a window on the developmental
  pathway of brain connectivity

* How can structural covariance affect treatment response?
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 1.0\textwidth 
[[file:iq_freesurfer_mccb.pdf]]
\center 
\tiny
Winkelbeiner et al., in prep.

** Right
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
#+ATTR_LATEX: :width 0.9\textwidth 
[[file:fe_iw2018_trampush2015.pdf]]
\center 
\tiny
Trampush et al. 2015, Schizophr Bull

* Another application of individual trajectories  
** Code                                                         :ignore:
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
#-----------------------------------------------------------------------
# demonstrate similarity of risperidone and aripiprazole
#-----------------------------------------------------------------------
source("bmi_load.R")
exweeks <- c(0, 1, 2, 3, 4, 6, 8, 10, 12)
bmif <- rbind(fef, feo) %>% filter(visit %in% exweeks) 

g3 <- ggplot(bmif, aes(x=as.factor(visit), y=weight, group=grid)) +
geom_line(aes(col=med)) +
#geom_point() +
theme_classic(base_size=30) +
theme(
	axis.title=element_text(face="bold"),
	axis.text=element_text(),
	legend.text=element_text(),
	legend.title=element_blank(),
  legend.key.height=unit(1.5, "line"),
	legend.position="right"
) +
scale_color_manual(values=c("dodgerblue4", "firebrick")) +
xlab("Week") +
ylab("Weight (lb)")


#p <- (plot_average(rbind(fef1, feo1) %>% filter(visit %in% exweeks)))
ggsave("../output/figures/fe_zh2018_homan2018c.pdf", plot=g3, width=12.5,
       height=6.99)
#-----------------------------------------------------------------------

#+END_SRC

** Slide                                                        :ignore:
#+ATTR_LATEX: :width 0.8\textwidth
file:fe_zh2018_homan2018c.pdf

* Individual trajectories and partial pooling
#+ATTR_LATEX: :width 0.9\textwidth 
[[file:fe_zh2018_homan2018d.pdf]]
\center 
\tiny
Homan et al., under review

* Striatal structure-function interaction predicts weight gain 
#+ATTR_LATEX: :width 0.8\textwidth 
[[file:fe_zh2018_homan2018e.png]]
\center 
\tiny
Homan et al., under review

* Clinical relevance
- Dichotomization may be appealing to clinicians but is statistically
  inefficient and biologically implausible 
- Decision making perspective: binary decision must be made at the point
  of actual clinical care, when all costs and potential benefits are
  known
- For example, a clinician may decide that a probable non-responder may
  still undergo treatment if the potential benefit outweighs the risk
  for that particular case

* Conclusion
- We need to be careful with dichotomizing patients
- Put enough effort in modeling response
- Partial pooling to exploit full information and apply shrinkage
* Outlook
\usebeamerfont{acknowledgments}
** Left
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Real-world indiv. differences in treatment outcome:
- Nation-wide electronic database from Finland 
-	All individuals 16 to 64 years in 2006 who received a diagnosis of
  schizophrenia during a period of 8 years (prevalent cohort)
- Repeated episodes on and off drugs
- Collaboration with Karolinska Inst. (Jari Tiihonen)

** Right 
:PROPERTIES: 
:BEAMER_col: 0.5 
:BEAMER_opt: [t]
:END:
Relapse prevention through digital health assistance:
- Multi-site study (10 centers, 342 patients)
- Technology-enhanced relapse prevention: Smartphone Intervention,
  Computerized CBT, Daily Support Website, Prescriber Decision Support
  System
- Results: Reduction of 4 days in re-hosp. compared to standard care
  (Homan, ..., Ben-Zeev, Robinson, Kane, in prep)

* Acknowledgments
# \footnotesize
\usebeamerfont{acknowledgments}
\singlespacing
** Left
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
*Mount Sinai School of Medicine* \\
-Daniela Schiller \\
-Roger Clem \\

\vspace{2mm}

*Feinstein Institute and Zucker Hillside Hospital* \\
-Stephanie Winkelbeiner \\
-Anil Malhotra \\
-Delbert Robinson \\
-John Kane \\

\vspace{2mm}

*University of Berne* \\
-Werner Strik \\
-Thomas Dierks \\

\vspace{2mm}

*Karolinska Institutet* \\
-Jari Tiihonen \\

\vspace{2mm}

** Right 
:PROPERTIES:
:BEAMER_col: 0.5
:BEAMER_opt: [t]
:END:
*University of Melbourne* \\
-Marialuisa Cavelti \\

\vspace{2mm}

*University of Edinburgh* \\
-David Carmel \\

\vspace{2mm}

*TU Munich* \\
-Stefan Leucht \\

\vspace{2mm}

*Yale University* \\
-Ifat Levy \\
-Ilan Harpaz-Rotem \\
-John Krystal \\

\vspace{2mm}

*NYU* \\
-Candace Raio \\
-Yaacov Trope \\

